Genome-Wide DNA Methylation Markers Associated With Metabolic Liver Cancer

Samuel O. Antwi , Ampem Darko Jnr. Siaw , Sebastian M. Armasu , Jacob A. Frank , Irene K. Yan , Fowsiyo Y. Ahmed , Laura Izquierdo-Sanchez , Loreto Boix , Angela Rojas , Jesus M. Banales , Maria Reig , Per Stål , Manuel Romero Gómez , Kirk J. Wangensteen , Amit G. Singal , Lewis R. Roberts , Tushar Patel
{"title":"Genome-Wide DNA Methylation Markers Associated With Metabolic Liver Cancer","authors":"Samuel O. Antwi ,&nbsp;Ampem Darko Jnr. Siaw ,&nbsp;Sebastian M. Armasu ,&nbsp;Jacob A. Frank ,&nbsp;Irene K. Yan ,&nbsp;Fowsiyo Y. Ahmed ,&nbsp;Laura Izquierdo-Sanchez ,&nbsp;Loreto Boix ,&nbsp;Angela Rojas ,&nbsp;Jesus M. Banales ,&nbsp;Maria Reig ,&nbsp;Per Stål ,&nbsp;Manuel Romero Gómez ,&nbsp;Kirk J. Wangensteen ,&nbsp;Amit G. Singal ,&nbsp;Lewis R. Roberts ,&nbsp;Tushar Patel","doi":"10.1016/j.gastha.2025.100621","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and Aims</h3><div>Metabolic liver disease is the fastest-rising cause of hepatocellular carcinoma (HCC), but the underlying molecular processes that drive HCC development in the setting of metabolic perturbations are unclear. We investigated the role of aberrant DNA methylation in metabolic HCC development in a multicenter international study.</div></div><div><h3>Methods</h3><div>We used a case-control design, frequency-matched on age, sex, and study site. Genome-wide profiling of peripheral blood leukocyte DNA was performed using the 850k EPIC array. The study sample was split 80% and 20% for training and validation. Cell type proportions were estimated from the methylation data. Differential methylation analysis was performed adjusting for cell type, generating area under the receiver-operating characteristic curves (AUC-ROC).</div></div><div><h3>Results</h3><div>We enrolled 272 metabolic HCC patients and 316 control patients with metabolic liver disease from 6 sites. Fifty-five differentially methylated CpGs were identified; 33 hypermethylated and 22 hypomethylated in cases vs controls. The panel of 55 CpGs discriminated between the cases and controls with AUC = 0.79 (95% confidence interval [CI] = 0.71–0.87), sensitivity = 0.77 (95% CI = 0.66–0.89), and specificity = 0.74 (95% CI = 0.64–0.85). The 55-CpG classifier panel performed better than a base model that comprised age, sex, race, and diabetes mellitus (AUC = 0.65, 95% CI = 0.55–0.75; sensitivity = 0.62, 95% CI = 0.49–0.75; and specificity = 0.64, 95% CI = 0.52–0.75). A multifactorial model that combined the 55 CpGs with age, sex, race, and diabetes yielded AUC = 0.78 (95% CI = 0.70–0.86), sensitivity = 0.81 (95% CI = 0.71–0.92), and specificity = 0.67 (95% CI = 0.55–0.78).</div></div><div><h3>Conclusion</h3><div>A panel of 55 blood leukocyte DNA methylation markers differentiates patients with metabolic HCC from control patients with benign metabolic liver disease, with a slightly higher sensitivity when combined with demographic and clinical information.</div></div>","PeriodicalId":73130,"journal":{"name":"Gastro hep advances","volume":"4 5","pages":"Article 100621"},"PeriodicalIF":0.0000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Gastro hep advances","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2772572325000081","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background and Aims

Metabolic liver disease is the fastest-rising cause of hepatocellular carcinoma (HCC), but the underlying molecular processes that drive HCC development in the setting of metabolic perturbations are unclear. We investigated the role of aberrant DNA methylation in metabolic HCC development in a multicenter international study.

Methods

We used a case-control design, frequency-matched on age, sex, and study site. Genome-wide profiling of peripheral blood leukocyte DNA was performed using the 850k EPIC array. The study sample was split 80% and 20% for training and validation. Cell type proportions were estimated from the methylation data. Differential methylation analysis was performed adjusting for cell type, generating area under the receiver-operating characteristic curves (AUC-ROC).

Results

We enrolled 272 metabolic HCC patients and 316 control patients with metabolic liver disease from 6 sites. Fifty-five differentially methylated CpGs were identified; 33 hypermethylated and 22 hypomethylated in cases vs controls. The panel of 55 CpGs discriminated between the cases and controls with AUC = 0.79 (95% confidence interval [CI] = 0.71–0.87), sensitivity = 0.77 (95% CI = 0.66–0.89), and specificity = 0.74 (95% CI = 0.64–0.85). The 55-CpG classifier panel performed better than a base model that comprised age, sex, race, and diabetes mellitus (AUC = 0.65, 95% CI = 0.55–0.75; sensitivity = 0.62, 95% CI = 0.49–0.75; and specificity = 0.64, 95% CI = 0.52–0.75). A multifactorial model that combined the 55 CpGs with age, sex, race, and diabetes yielded AUC = 0.78 (95% CI = 0.70–0.86), sensitivity = 0.81 (95% CI = 0.71–0.92), and specificity = 0.67 (95% CI = 0.55–0.78).

Conclusion

A panel of 55 blood leukocyte DNA methylation markers differentiates patients with metabolic HCC from control patients with benign metabolic liver disease, with a slightly higher sensitivity when combined with demographic and clinical information.

Abstract Image

求助全文
约1分钟内获得全文 求助全文
来源期刊
Gastro hep advances
Gastro hep advances Gastroenterology
CiteScore
0.80
自引率
0.00%
发文量
0
审稿时长
64 days
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信